Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
JAP Da Silva, JWG Jacobs, JR Kirwan… - Annals of the …, 2006 - ard.bmj.com
Adverse effects of glucocorticoids have been abundantly reported. Published reports on low
dose glucocorticoid treatment show that few of the commonly held beliefs about their …
dose glucocorticoid treatment show that few of the commonly held beliefs about their …
Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations
EL Romero, MJ Morilla - International journal of Nanomedicine, 2013 - Taylor & Francis
Vesicles that are specifically designed to overcome the stratum corneum barrier in intact skin
provide an efficient transdermal (systemic or local) drug delivery system. They can be …
provide an efficient transdermal (systemic or local) drug delivery system. They can be …
[HTML][HTML] Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage
G Cevc, G Blume - Biochimica et Biophysica Acta (BBA)-Biomembranes, 2004 - Elsevier
We characterised biological properties of novel formulations of two low-potency
glucocorticosteroids, dexamethasone and hydrocortisone, which have an equivalent dose …
glucocorticosteroids, dexamethasone and hydrocortisone, which have an equivalent dose …
[HTML][HTML] Glucocorticoid therapy and adrenal suppression
NC Nicolaides, AN Pavlaki, M Alexandra, GP Chrousos - 2015 - europepmc.org
Glucocorticoids are steroid hormones produced by the adrenal cortex. They have pleiotropic
effects and contribute substantially to the maintenance of resting and stress-related …
effects and contribute substantially to the maintenance of resting and stress-related …
Side effects of glucocorticoids
IS Alan, B Alan - Pharmacokinetics and adverse effects of drugs …, 2018 - books.google.com
Glucocorticoids represent the most important and frequently used class of drugs in the
management of many inflammatory and immunologic conditions. Beside these beneficial …
management of many inflammatory and immunologic conditions. Beside these beneficial …
Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants
JA Couto, AK Greene - Journal of Plastic, Reconstructive & Aesthetic …, 2014 - Elsevier
Background Intralesional corticosteroid is one method used to limit the rapid growth of
infantile hemangiomas. The purpose of this study was to determine the efficacy and safety of …
infantile hemangiomas. The purpose of this study was to determine the efficacy and safety of …
Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application
L Shen, Y You, S Sun, Y Chen, J Qu, L Cheng - Ophthalmology, 2010 - Elsevier
PURPOSE: To characterize the pharmacokinetics of triamcinolone acetonide (TA) in
aqueous, vitreous, and systemic circulation after a single subtenon injection. DESIGN …
aqueous, vitreous, and systemic circulation after a single subtenon injection. DESIGN …
Therapeutic doses of glucocorticoids: implications for oral medicine
SK Baid, LK Nieman - Oral diseases, 2006 - Wiley Online Library
Glucocorticoids can cause adverse systemic side‐effects ranging from iatrogenic Cushing's
syndrome during treatment, to hypothalamic–pituitary–adrenal axis suppression and …
syndrome during treatment, to hypothalamic–pituitary–adrenal axis suppression and …
Co-administration of 5α-reductase inhibitors worsens the adverse metabolic effects of prescribed glucocorticoids
Abstract Context Glucocorticoids (GCs) are commonly prescribed, but their use is associated
with adverse metabolic effects. 5α-reductase inhibitors (5α-RI) are also frequently …
with adverse metabolic effects. 5α-reductase inhibitors (5α-RI) are also frequently …
Plasma biomarker profiling in the detection of growth promoter use in calves
MH Mooney, C Situ, G Cacciatore, T Hutchinson… - Biomarkers, 2008 - Taylor & Francis
The detection of illicit growth promoter use during meat production within the European
Union is reliant on residue testing which is a limiting factor on the number of animals which …
Union is reliant on residue testing which is a limiting factor on the number of animals which …